Suchergebnisse - "Gyawali, Bishal"

PubPharm (8)

1

Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer

enthalten in: The Lancet. Oncology | 2023

von Meirson, T. | Goldstein, D. | Gyawali, B. | +1

CommentIn: Lancet Oncol. 2023 Jun;24(6):e238. - PMID 37146620

2

Aumolertinib in EGFR-Mutant Lung Cancer : Will the Promise of Cost Disruption Ease Access?

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Aggarwal, C. | Gyawali, B.

CommentOn: J Clin Oncol. 2022 Sep 20;40(27):3162-3171. - PMID 35580297

3

Evaluation of Information Theoretic Network Meta-analysis to Rank First-Line Anticancer Regimens for Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer

enthalten in: JAMA network open | 2022

von Li, X. | Beeghly-Fadiel, A. | Bhavnani, S. | +6

CommentIn: JAMA Netw Open. 2022 Apr 1;5(4):e224380. - PMID 35416996

4

Can locally developed me-too drugs aid price negotiation? An example of cancer therapies from China

enthalten in: Seminars in oncology | 2021

von Luo, Z. | Gyawali, B. | Han, S. | +3

5

Lessons From ADAURA on Adjuvant Cancer Drug Trials : Evidence, Ethics, and Economics

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Gyawali, B. | West, H.

6

Optimal duration of adjuvant trastuzumab in treatment of early breast cancer : a meta-analysis of randomized controlled trials

enthalten in: Breast cancer research and treatment | 2019

von Niraula, S. | Gyawali, B.

7

Duration of adjuvant trastuzumab in HER2 positive breast cancer : Overall and disease free survival results from meta-analyses of randomized controlled trials

enthalten in: Cancer treatment reviews | 2017

von Gyawali, B. | Niraula, S.

8

Unconvincing Benefit of Combination Therapy With Gefitinib and Pemetrexed in Advanced Non-Small-Cell Lung Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2017

von Ota, A. | Gyawali, B. | Matsuoka, A. | +1

CommentOn: J Clin Oncol. 2016 Sep 20;34(27):3258-66. - PMID 27507876

1
[1]